Medxy AI

Efficacy and Safety of Low-Dose Rivaroxaban in Advanced Chronic Kidney Disease with High Cardiovascular Risk: A Comprehensive Review

By MedXY 09/20/2026

Low-dose rivaroxaban failed to reduce cardiovascular events but increased major bleeding in advanced CKD patients at high cardiovascular risk, underscoring the need for cautious anticoagulant use.

Hematology-Oncology news Oncology

Distinct Roles of PD-L1 and PD-L2 in Primary Mediastinal Large B-Cell Lymphoma: Implications for Immune Therapeutics

By MedXY 09/20/2026

This article explores how PD-L1 and PD-L2 differentially regulate immune and lineage-specific programs in primary mediastinal large B-cell lymphoma, providing insights for tailored immunotherapy.

Hematology-Oncology news Rheumatology

Unraveling Neutrophil-Driven Interferonopathy in Hemophilic Arthropathy: A New Therapeutic Target

By MedXY 09/20/2026

This study identifies neutrophil-dependent type-I interferon responses and NETs as key drivers of joint damage in hemophilia A, opening avenues for novel therapies to prevent hemophilic arthropathy.

Infectious Diseases news Respiratory

East Asia-Specific Mycobacterium massiliense ST120: Phylogenomics, Clinical Impact, and Challenges in Pulmonary Disease Management

By MedXY 09/20/2026

The ST120 strain of Mycobacterium massiliense, prevalent in East Asia, exhibits unique genetic features linked to increased virulence and worse treatment outcomes in pulmonary disease.

news Ophthalmology

LYNX-1 Phase 3 Trial: Phentolamine Ophthalmic Solution for Dim Light Vision Disturbances

By MedXY 09/20/2026

The Phase 3 LYNX-1 trial demonstrates that 0.75% phentolamine ophthalmic solution improves mesopic low-contrast visual acuity and reduces photic symptoms in patients with dim light vision disturbances, including those post-keratorefractive surgery, with a good safety profile.

news Oncology Otorhinolaryngology

Unraveling the Role of LINC01521 in Papillary Thyroid Carcinoma: Prognostic Potential and Molecular Mechanisms

By MedXY 09/20/2026

LINC01521 is significantly upregulated in papillary thyroid carcinoma, promoting tumor progression by targeting miR-4319 and inhibiting cuproptosis, thereby serving as an independent prognostic marker for adverse clinical outcomes.

Gastroenterology General Surgery news

Xenotransplantation in Acute Liver Failure: Bridging the Organ Gap with Genetically Modified Porcine Livers

By MedXY 09/20/2026

This article reviews advances in liver xenotransplantation using genetically modified porcine organs as a bridging strategy for acute liver failure, highlighting recent clinical progress, challenges, and future directions.

Gastroenterology Infectious Diseases news

Dissecting Gut-Vascular Barrier Failures: Macrophage Dysfunction Drives Bacterial Translocation in Cirrhosis

By MedXY 09/20/2026

This study elucidates how intestinal blood vessel-associated macrophage dysfunction contributes to gut-vascular barrier breakdown and bacterial translocation in cirrhosis, revealing novel mechanisms that underlie systemic infection risks in liver disease.

Diabetes & Endocrinology news OB/GYN & Women's Health

Harmonizing Estradiol Reference Ranges in Postmenopausal Women: A Breakthrough for Accurate Hormone Assessment and Risk Prediction

By MedXY 09/20/2026

This article reviews the establishment of international standardized reference ranges for plasma estradiol in postmenopausal women, highlighting the influence of BMI and assay harmonization using CDC standards, with implications for therapy monitoring and disease risk evaluation.

Cardiology news Oncology

Breast Cancer-Derived ADAM10: A Novel Mediator of Atrial Fibrillation Through Atrial Fibrosis

By MedXY 09/20/2026

Breast cancer independently increases atrial fibrillation risk via tumour-secreted ADAM10, which induces atrial fibrosis through the Ephrin B2 signaling pathway, offering a potential new therapeutic target.

Neurology news Ophthalmology

Retinal OCTA as a Window into Cerebral Small Vessel Disease and Cognitive Decline Post-Stroke

By MedXY 09/20/2026

This longitudinal study shows that retinal microvascular changes measured by OCTA correspond with cerebral small vessel disease progression and cognitive decline in mild ischemic stroke patients, highlighting OCTA's potential as a noninvasive biomarker for brain vascular health.

$Prognostic Factors and Role of Allo-HSCT in First Salvage Therapy for Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia Treated with Blinatumomab and Inotuzumab Ozogamicin$

Hematology-Oncology news Oncology

Prognostic Factors and Role of Allo-HSCT in First Salvage Therapy for Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia Treated with Blinatumomab and Inotuzumab Ozogamicin

By MedXY 09/20/2026

Early measurable residual disease (MRD) negativity and timing of relapse are crucial for risk stratification in adults with relapsed/refractory B-cell acute lymphoblastic leukemia (B-ALL) treated with blinatumomab and/or inotuzumab ozogamicin. Allogeneic stem cell transplantation (allo-HSCT) benefits select high-risk patients.

Critical Care news Respiratory

Distinct Weaning Phenotypes in Invasive Mechanical Ventilation Failures: Insights from the WEAN SAFE Cohort

By MedXY 09/20/2026

This study identifies three distinct phenotypes among patients failing to wean from invasive mechanical ventilation, linking failed initial attempts, withdrawal decisions, and mortality, highlighting the need for tailored management strategies in critical care.

Anesthesiology Critical Care news

Low-Dose Ketamine Reduces Opioid Requirements in Mechanically Ventilated ICU Patients: Insights from a Double-Blind Randomized Trial

By MedXY 09/20/2026

A randomized controlled trial demonstrates that adjunct low-dose ketamine infusion safely decreases opioid use in mechanically ventilated adults without increasing delirium or adverse events, suggesting potential benefits in ICU analgosedation strategies.

Critical Care news

Enabling Driving Resumption in ICU Survivors: Insights from a Comprehensive Driving Assessment Study

By MedXY 09/20/2026

This study evaluates driving ability and resumption in adult ICU survivors after critical illness, identifying impairments and demonstrating that targeted interventions enable many to safely resume driving, enhancing post-ICU functional recovery.

Emergency Medicine news

Defining Diagnostic Excellence and Missed Diagnostic Opportunity in the Emergency Department: Key Consensus Recommendations for Practice and Research

By MedXY 09/20/2026

A multidisciplinary RAND/UCLA consensus defines 'diagnostic excellence' and 'missed diagnostic opportunity' for emergency departments, offering clear conceptual components to guide measurement, research, and quality improvement.

Emergency Medicine news Psychiatry

Dexmedetomidine Continuous Infusion to Maintain Sedation in Severely Agitated Adolescents in the Emergency Department: A Case Series Report

By MedXY 09/20/2026

This report describes the use of dexmedetomidine infusion for sedation in severely agitated adolescents in the ED, highlighting its feasibility as a bridge therapy while awaiting psychiatric care.

Internal Medicine news

Innovative Clinical Research Training for Medical Undergraduates: Enhancing Competency through Authentic Mentorship and Practice

By MedXY 09/20/2026

A novel educational model embedding clinical research training within real-world trials improves medical students’ research skills, fosters evidence-based thinking, and bridges clinical and academic integration.

Critical Care Internal Medicine news

Enhancing Interprofessional Teamwork in ICU: Developing Entrustable Professional Activities for Trainees and Advanced Practice Providers

By MedXY 09/20/2026

This article discusses the design and evaluation of entrustable professional activities (EPAs) promoting effective teamwork and psychological safety among trainees and advanced practice providers in ICU settings.

AI Internal Medicine news

Ethics and Professionalism in AI and Medical Practice: Key Guidance from the American College of Physicians (2026 Position Paper)

By MedXY 09/20/2026

The ACP's 2026 position paper offers clinician-focused ethical guidance for AI use in medicine, emphasizing relationality, self-governance, and competence to safeguard patient welfare, equity, transparency, and clinical judgment.